HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seong-Gyu Ko Selected Research

Weight Loss (Weight Reduction)

6/2020Efficacy and safety of Euiiyin-tang in Korean women with obesity: A randomized, double-blind, placebo-controlled, multicenter trial.
1/2017Euiiyin-tang in the treatment of obesity: study protocol for a randomised controlled trial.
11/2016Synergistic Effect of SH003 and Doxorubicin in Triple-negative Breast Cancer.
1/2016Angelica acutiloba Kitagawa Extract Attenuates DSS-Induced Murine Colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seong-Gyu Ko Research Topics

Disease

75Neoplasms (Cancer)
05/2024 - 03/2005
25Breast Neoplasms (Breast Cancer)
02/2023 - 02/2009
15Inflammation (Inflammations)
09/2023 - 03/2009
11Lung Neoplasms (Lung Cancer)
05/2024 - 11/2008
10Atopic Dermatitis (Atopic Eczema)
09/2023 - 01/2012
9Stomach Neoplasms (Stomach Cancer)
09/2021 - 07/2006
8Anorexia
01/2023 - 01/2014
7Allergic Rhinitis
11/2021 - 01/2014
6Obesity
07/2020 - 04/2012
5Edema (Dropsy)
01/2023 - 01/2010
5Body Weight (Weight, Body)
02/2022 - 04/2012
5Prostatic Neoplasms (Prostate Cancer)
01/2022 - 12/2016
4Melanoma (Melanoma, Malignant)
03/2024 - 01/2010
4Neuralgia (Stump Neuralgia)
11/2023 - 01/2021
4Squamous Cell Carcinoma of Head and Neck
10/2023 - 09/2021
4Carcinoma (Carcinomatosis)
01/2023 - 05/2004
4Hyperalgesia
06/2022 - 01/2021
4Diarrhea
02/2022 - 03/2009
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2008
4Ovarian Neoplasms (Ovarian Cancer)
11/2021 - 04/2016
4Weight Loss (Weight Reduction)
06/2020 - 01/2016
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 01/2020
3Pain (Aches)
11/2023 - 08/2021
3Demyelinating Diseases (Demyelinating Disease)
04/2023 - 01/2021
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
04/2023 - 01/2021
3Hypoxia (Hypoxemia)
01/2023 - 01/2020
3Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 01/2018
3Neoplasm Metastasis (Metastasis)
03/2022 - 01/2013
3Hypersensitivity (Allergy)
11/2021 - 01/2010
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 01/2020
3Cold Hypersensitivity
04/2019 - 01/2017
3Necrosis
11/2018 - 05/2014
3Cachexia
01/2017 - 01/2014
2Metabolic Diseases (Metabolic Disease)
05/2024 - 01/2020
2Peripheral Nervous System Diseases (PNS Diseases)
11/2023 - 01/2021
2Ischemic Stroke
02/2023 - 06/2012

Drug/Important Bio-Agent (IBA)

14Plant ExtractsIBA
01/2023 - 01/2013
9Reactive Oxygen Species (Oxygen Radicals)IBA
03/2024 - 06/2014
9Cisplatin (Platino)FDA LinkGeneric
04/2023 - 03/2009
8Ethanol (Ethyl Alcohol)IBA
11/2023 - 07/2006
8Paclitaxel (Taxol)FDA LinkGeneric
11/2023 - 04/2016
8CytokinesIBA
04/2023 - 01/2012
7Docetaxel (Taxotere)FDA Link
05/2024 - 09/2020
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 11/2009
6Biomarkers (Surrogate Marker)IBA
05/2024 - 07/2015
6Immunoglobulin E (IgE)IBA
11/2021 - 06/2010
6juzentaihotoIBA
04/2019 - 01/2014
6STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
12/2017 - 01/2013
5AntioxidantsIBA
06/2023 - 01/2010
5Messenger RNA (mRNA)IBA
10/2022 - 01/2012
5LipidsIBA
01/2022 - 04/2012
5QuercetinIBA
01/2021 - 11/2008
5DSGOSTIBA
01/2018 - 04/2016
5ApigeninIBA
08/2017 - 07/2012
4Dinitrochlorobenzene (DNCB)IBA
09/2023 - 01/2012
4Therapeutic UsesIBA
04/2023 - 01/2014
4Proteins (Proteins, Gene)FDA Link
01/2023 - 02/2009
4cucurbitacin DIBA
01/2022 - 01/2013
4Phytoestrogens (Phytoestrogen)IBA
10/2015 - 10/2011
3Anti-Bacterial Agents (Antibiotics)IBA
09/2023 - 04/2021
3InterleukinsIBA
04/2023 - 04/2012
3Myelin-Oligodendrocyte GlycoproteinIBA
04/2023 - 01/2021
3costunolideIBA
02/2023 - 04/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 04/2016
3VimentinIBA
03/2022 - 11/2021
3Transcription Factors (Transcription Factor)IBA
03/2022 - 01/2013
3Oxygen (Dioxygen)IBA
03/2022 - 04/2016
3Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 12/2016
3SaponinsIBA
01/2022 - 03/2005
3FlavonoidsIBA
01/2020 - 07/2016
3Histamine Antagonists (Antihistamines)IBA
03/2017 - 11/2013
3AdiponectinIBA
11/2016 - 01/2013
3CaspasesIBA
07/2016 - 11/2008
3buteinIBA
04/2016 - 06/2014
3OvalbuminIBA
01/2016 - 01/2012
3bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
10/2015 - 02/2011
3Caspase 3 (Caspase-3)IBA
02/2011 - 10/2004
2decursinIBA
05/2024 - 12/2016
2LigandsIBA
03/2024 - 11/2020
2Phosphotransferases (Kinase)IBA
12/2023 - 05/2016
2Flavin Mononucleotide (FMN)IBA
06/2023 - 01/2023
2Pemetrexed (MTA)FDA Link
04/2023 - 01/2020
2EnzymesIBA
04/2023 - 01/2019
2Neuroprotective AgentsIBA
04/2023 - 01/2021
2ChemokinesIBA
04/2023 - 10/2021
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
04/2023 - 01/2014
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2023 - 01/2014
2phorbolIBA
01/2023 - 11/2018
2Thymic Stromal LymphopoietinIBA
01/2023 - 09/2021
2shogaolIBA
01/2023 - 06/2022
2gingerolIBA
01/2023 - 03/2022
2Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2022 - 08/2021

Therapy/Procedure

24Therapeutics
05/2024 - 07/2006
14Drug Therapy (Chemotherapy)
11/2021 - 09/2010
14Traditional Medicine (Folk Remedies)
10/2021 - 03/2008
9Oral Administration
11/2023 - 03/2008
6Complementary Therapies (Alternative Medicine)
09/2023 - 01/2014
6East Asian Traditional Medicine (Oriental Medicine)
01/2017 - 08/2007
5Radiotherapy
10/2023 - 09/2021
3Immunotherapy
03/2024 - 09/2021